![](https://i0.wp.com/www.healthinnowest.net/wp-content/uploads/2023/05/medtech-research.jpeg?fit=772%2C476&ssl=1)
“The NHS Long Term Plan identifies antimicrobial resistance as one of five priorities requiring NHS action on prevention, and reiterates the UK’s 20-year vision for AMR which outlines the aim for a world in which antimicrobial resistance is effectively contained, controlled and mitigated. AMR is a significant threat to public health and this programme is looking for innovations that can help.“
Under the overall theme of “Antimicrobial resistance (AMR)”, Competition 25 Phase 1 invites early-stage innovations in the following four priority areas:
- Point of care diagnostics, monitoring, and susceptibility testing
- Prescribing decision support and risk stratification
- Novel care delivery methods
- Infection prevention and control (IPC).
The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
Single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public and third sectors, including companies (large corporates and small and medium enterprises), charities, universities, and NHS providers, given a strong commercial strategy is provided, are eligible to apply.
Applications open
17 July 2024
Applications Close
28 August 2024 1:00 pm
Further information
Back